Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab\u27s Efficacy in MTX iNadequate rEsponders (SERENE))
- Publication date
- 1 September 2010
- Publisher
- BMJ Group